About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Houston | 155 Studies

Clinical Trials Alzheimer's DiseaseHouston

Alzheimer's Disease Clinical Trials in Houston

Find 155 clinical trials for alzheimer's disease near Houston, Texas. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 155 trials

CompletedA Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.NCT04777409·Phoenix, Arizona and 497 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedDHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's DiseaseThe purpose of this study is to determine whether chronic DHA (Docosahexaenoic Acid) supplementation slows the progression of cognitive and functional decline in mild to moderate…NCT00440050·Birmingham, Alabama and 50 others

Active not recruitingA Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.NCT04437511·Gilbert, Arizona and 273 others

TerminatedA Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to evaluate the safety and efficacy of five fixed dosage levels of FK962 or placebo for 24 weeks in subjects with mild to moderate Alzheimer's disease.NCT00087724·Phoenix, Arizona and 83 others

Terminated221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's DiseaseThe primary objective of the study is to evaluate the efficacy of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical…NCT02484547·Birmingham, Alabama and 179 others

CompletedAmyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's DiseaseThis study in individuals with early Alzheimer's disease is designed to assess:(1) safety and tolerability (2) the capacity of ACC-001 and QS-21 adjuvant to reduce brain amyloid…NCT01227564·Phoenix, Arizona and 39 others

CompletedBapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)This is a multicenter, double-blind, placebo controlled, randomized, outpatient multiple dose study in male and female patients ages 50 to less than 89 years with mild to moderate…NCT00574132·Birmingham, Alabama and 250 others

TerminatedA Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging AbnormalitiesThe primary objective of the study is to assess the safety impact of continuing aducanumab dosing in asymptomatic Amyloid-related Imaging Abnormalities (ARIA) in participants with…NCT03639987·Phoenix, Arizona and 21 others

TerminatedAn Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD)The purpose of this study is to assess the long-term safety and tolerability of ABBV-8E12 in participants with early AD.NCT03712787·Phoenix, Arizona and 56 others

CompletedA Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)The primary specific aim of this clinical trial is to determine whether treatment with rofecoxib or naproxen for one year will slow the rate of decline of cognitive function in…NCT00004845·Phoenix, Arizona and 39 others

CompletedMemory Impairment Study (Mild Cognitive Impairment Study)The National Institute on Aging (NIA) is launching a nationwide treatment study targeting individuals with mild cognitive impairment (MCI), a condition characterized by a memory…NCT00000173·Phoenix, Arizona and 71 others

TerminatedStudy to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeThis study was conducted to evaluate the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide \[d6-DM\]/quinidine sulfate \[Q\]) compared to placebo for…NCT04464564·Phoenix, Arizona and 105 others

Active not recruitingA Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's DiseaseThis is a multicenter randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to…NCT05531656·Birmingham, Alabama and 49 others

CompletedAAB-001 in Patients With Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to assess the safety and tolerability of multiple doses of AAB-001 passive immunization in patients with mild to moderate Alzheimer's disease (AD).NCT00112073·Sun City, Arizona and 25 others

TerminatedA 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's DiseaseThe name of this trial is MissionAD1.NCT02956486·Chandler, Arizona and 257 others

CompletedPhase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to HistopathologyTo determine the sensitivity and specificity of the visual assessment of tracer uptake in the Florbetaben PET images compared to histological verification of the presence or…NCT01020838·Sun City, Arizona and 18 others

RecruitingNON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASEThe goal of this clinical trial is to learn if repetitive transcranial magnetic stimulation (rTMS), a non-invasive form of brain stimulation, can improve short-term memory in…NCT07667478·Houston, Texas

CompletedThe PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) AmyloidosisThis is a global, multicenter, Phase 2b, randomized, double-blind, placebo-controlled, two-arm, parallel-group efficacy and safety study of NEOD001 as a single agent administered…NCT02632786·Duarte, California and 39 others

CompletedPTI-125 for Mild-to-moderate Alzheimer's Disease PatientsThis is a Phase 2b, Randomized, Double-blind, Placebo-controlled, multiple dose study of PTI-125 in mild-to-moderate Alzheimer's disease patients.NCT04079803·Gilbert, Arizona and 8 others

Active not recruitingA Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's DiseaseThis study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiority of lecanemab compared with…NCT03887455·Phoenix, Arizona and 246 others

Page 1 of 8Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia